Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
March 2, 2018	4	Statement of changes in beneficial ownership of securities	0001562180-18-001386.pdf 0001562180-18-001386.rtf 0001562180-18-001386.xls View HTML
February 16, 2018	4	Statement of changes in beneficial ownership of securities	0001562180-18-001042.pdf 0001562180-18-001042.rtf 0001562180-18-001042.xls View HTML
February 14, 2018	SC 13G/A	An amendment to the SC 13G filing	0001144204-18-008432.pdf 0001144204-18-008432.rtf 0001144204-18-008432.xls View HTML
February 13, 2018	SC 13G	A statement of beneficial ownership of common stock by certain persons	0001193125-18-040491.pdf 0001193125-18-040491.rtf 0001193125-18-040491.xls View HTML
January 29, 2018	SC 13G/A	An amendment to the SC 13G filing	0000215457-18-003721.pdf 0000215457-18-003721.rtf View HTML
January 26, 2018	S-8	Securities offered to employees pursuant to employee benefit plans	0001193125-18-021657.pdf 0001193125-18-021657.rtf 0001193125-18-021657.xls View HTML
January 8, 2018	SC 13G/A	An amendment to the SC 13G filing	0000790502-18-000001.pdf 0000790502-18-000001.rtf View HTML
November 28, 2017	CT ORDER	CT ORDER	9999999997-17-010082.pdf View HTML
November 8, 2017	10-Q	Quarterly report which provides a continuing view of a company's financial position	0001564590-17-022727.pdf 0001564590-17-022727.rtf 0001564590-17-022727.xls EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
November 7, 2017	SC 13G/A	An amendment to the SC 13G filing	0001104659-17-066647.pdf 0001104659-17-066647.rtf 0001104659-17-066647.xls View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax